M7633
4-甲基伞形酮-α-D-半乳糖苷
≥98% (TLC)
别名:
MU-alpha-GAL
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C16H18O8
化学文摘社编号:
分子量:
338.31
UNSPSC Code:
12352204
NACRES:
NA.32
PubChem Substance ID:
EC Number:
254-031-1
Beilstein/REAXYS Number:
94674
MDL number:
产品名称
4-甲基伞形酮-α-D-半乳糖苷, ≥98% (TLC)
InChI key
YUDPTGPSBJVHCN-CHUNWDLHSA-N
InChI
1S/C16H18O8/c1-7-4-12(18)23-10-5-8(2-3-9(7)10)22-16-15(21)14(20)13(19)11(6-17)24-16/h2-5,11,13-17,19-21H,6H2,1H3/t11-,13+,14+,15-,16+/m1/s1
SMILES string
CC1=CC(=O)Oc2cc(O[C@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3O)ccc12
assay
≥98% (TLC)
form
powder
solubility
water: 50 mg/mL, clear, colorless to very faintly yellow
fluorescence
λex 317 nm; λem 374 nm (pH 9.1)
λex 360 nm; λem 449 nm (Reaction product)
storage temp.
−20°C
Quality Level
正在寻找类似产品? 访问 产品对比指南
Application
4-甲基伞形基-α-D-吡喃半乳糖苷已用作人工底物，测定 α-半乳糖苷酶-A 活性。
Biochem/physiol Actions
4-甲基伞形基α-D-吡喃半乳糖苷是 α-半乳糖苷酶-A 的荧光底物。这种酶将底物转化为蓝色荧光产物甲基伞形花。通过分光光度法测定荧光强度。
Preparation Note
4-甲基伞形酮α-D-吡喃半乳糖苷可溶于水(50 mg/ml)，形成无色至淡黄色的澄清溶液（加热处理后）。
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
法规信息
涉药品监管产品
此项目有
Nathaniel G Hentz et al.
Journal of laboratory automation, 19(2), 153-162 (2013-09-14)
This study illustrates how optimization of both liquid-handling accuracy and precision is critical to assay performance. The study was designed to examine (1) liquid-handling performance and (2) the effect of liquid-handling variability on two types of in vitro biochemical assays
Eugènia Ruiz-Cánovas et al.
Colloids and surfaces. B, Biointerfaces, 208, 112123-112123 (2021-09-28)
The capability of HeLa cells to internalize large spherical microparticles has been evaluated by using inorganic, magnetic microparticles of 1 and 2.8 µm of diameter. In both absence but especially under the action of a magnet, both types of particles were
Zhen-Dan Shi et al.
Analytical and bioanalytical chemistry, 394(7), 1903-1909 (2009-06-13)
Alpha-galactosidase A hydrolyzes the terminal alpha-galactosyl moieties from glycolipids and glycoproteins in lysosomes. Mutations in alpha-galactosidase cause lysosomal accumulation of the glycosphingolipid, globotriaosylceramide, which leads to Fabry disease. Small-molecule chaperones that bind to mutant enzyme proteins and correct their misfolding
Tali Kizhner et al.
Molecular genetics and metabolism, 114(2), 259-267 (2014-08-27)
Fabry disease is an X-linked recessive disorder caused by the loss of function of the lysosomal enzyme α-Galactosidase-A. Although two enzyme replacement therapies (ERTs) are commercially available, they may not effectively reverse some of the Fabry pathology. PRX-102 is a
S J Park et al.
Applied and environmental microbiology, 61(5), 2027-2029 (1995-05-01)
With a spectrofluorometer, the length of the incubation time required in the fluorogenic assay was reduced to 12 h. The threshold emissions for reading the fluorogenic reaction by the spectrofluorometer were 5 and 10 U for lauryl tryptose broth media
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持